Expert Discusses the Importance of C. Diff Awareness, Future Treatments

Video

Debra Goff, PharmD, FIDSA, FCCP, infectious diseases specialist at the Ohio State University Wexner Medical Center, discusses Clostridioides difficile awareness and potential future treatments.

In a Pharmacy Times® interview, Debra Goff, PharmD, FIDSA, FCCP, infectious diseases specialist at the Ohio State University Wexner Medical Center and professor of Pharmacy Practice at the Ohio State University College of Pharmacy, reviews what makes Clostridioides difficile (C. diff) awareness critical, and highlights the work of the Peggy Lillis Foundation.

In this discussion, Goff covers the risk factors for contracting C. diff, current available treatments, and the future of C. diff treatment. She also details the efforts of the Peggy Lillis Foundation to raise awareness of this disease.

Related Videos
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Medicine law concept. Judges gavel with pills | Image Credit: Iren Moroz - stock.adobe.com
Image credit: New Africa | stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image Credit: Pixel-Shot | stock.adobe.com
Pharmacist holding medicine box and capsule pack in pharmacy drugstore. -- Image credit: I Viewfinder | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.